Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AbbVie’s First Forecast is Higher Than Estimates
Bloomberg
Wednesday, January 30, 2013 - 10:49am
tags:
AbbVie
Ventrus Biosciences Announces $20 Million Financing
Yahoo
Wednesday, January 30, 2013 - 10:49am
tags:
Ventrus
AbbVie CEO Says Humira Will Blunt $1B Hit To Lipid Franchise
Forbes
Wednesday, January 30, 2013 - 10:48am
tags:
Rick Gonzalez, Humira, AbbVie
What's in Regeneron's Pipes?
Motley Fool
Wednesday, January 30, 2013 - 10:42am
tags:
Regeneron, Sanofi, REGN688, Eylea, Sarilumab
FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
Forbes
Wednesday, January 30, 2013 - 10:36am
tags:
mipomersen, Kynamro, Isis Pharmaceuticals, Homozygous Familial Hypercholesterolemia, Genzyme, FDA
Pfizer Will Consider Split of Drug Units, CEO Read Says
Bloomberg
Wednesday, January 30, 2013 - 10:34am
tags:
Pfizer, Ian Read, generics
The Obesity Epidemic: EnteroMedics' New Treatment Approach
Seeking Alpha
Tuesday, January 29, 2013 - 11:09am
tags:
obesity, EnteroMedics, Acadia, Vivus, Orexigen, Arena Pharmaceuticals
Anacor Falls On Positive But Disappointing Toenail Fungus Data
TheStreet.com
Tuesday, January 29, 2013 - 11:07am
tags:
Anacor, Tavaborole, Onychomycosis
Stem Cell Therapy Companies: Underappreciated Outperformers
Seeking Alpha
Tuesday, January 29, 2013 - 11:05am
tags:
stem cells, Athersys, NeoStem, Advanced Cell Technology, Amarantus BioSciences, Osiris, RTI Biologics, StemCells
New Drug Could Enhance the Accuracy of Chemotherapy
Yahoo
Tuesday, January 29, 2013 - 10:31am
tags:
chemotherapy, CytRx
GSK in Joint Venture for Pediatric Vaccine
Pharm Tech
Tuesday, January 29, 2013 - 10:29am
tags:
GSK, vaccines, Biological E
And Now, For Some More Pharma Layoffs…
Pharmalot
Tuesday, January 29, 2013 - 10:28am
tags:
layoffs
Allergan wins round in patent fight over Lumigan
Reuters
Tuesday, January 29, 2013 - 10:27am
tags:
Allergan, patents, Lumigan, Teva, Sandoz, glaucoma
Generic Launch at Dr. Reddy's
Yahoo/Zacks
Tuesday, January 29, 2013 - 10:25am
tags:
generics, Dr Reddy's, Merck, Clarinex
Bristol-Myers Squibb's Dividend Increase And Promising New Drugs
Seeking Alpha
Tuesday, January 29, 2013 - 10:23am
tags:
dividend, Bristol-Myers Squibb, Eliquis, Yervoy, PDL-1, Abilify, Forixga
Should Johnson & Johnson Break Up?
Motley Fool
Tuesday, January 29, 2013 - 10:21am
tags:
JNJ
Illumina Beats on Both Top and Bottom Lines
Motley Fool
Tuesday, January 29, 2013 - 9:26am
tags:
Illumina, earnings
Eli Lilly has no plans to shed its Elanco animal health unit
The Fly on the Wall
Tuesday, January 29, 2013 - 9:25am
tags:
Eli Lilly, Elanco, animal health
Redhill Seeks Migraine, Oncology Partners After Nasdaq Listing
Bloomberg
Tuesday, January 29, 2013 - 9:24am
tags:
migraines, oncology, Redhill Biopharma
Lilly Profit Beats Analyst Estimates as Cymbalta Sales Climb
Bloomberg
Tuesday, January 29, 2013 - 9:22am
tags:
earnings, Eli Lilly

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.